Diagnostic POCUS of Patellar Tendinopathy in Female Athletes

NCT ID: NCT05880277

Last Updated: 2023-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-17

Study Completion Date

2025-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: The purpose of this study is to determine the clinical effectiveness of point-of-care diagnostic ultrasound in the assessment of patellar tendon pathologies

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will receive information about the study and informed consent will be provided. Participants will voluntarily agree to be a participant in the study. Participants will sign the informed consent, and complete the POCUS demographic information sheet, if they qualify then they will have both of their patellar tendons examined through the use of the Butterfly IQ diagnostic ultrasound. Following the examination, they will complete the Knee Injury and Osteoarthritis Outcome Score (KOOS) and the Knee Injury and Osteoarthritis Outcome Patellofemoral subscale (KOOS-PF) and then complete the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patellofemoral Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

female collegiate jumping athletes
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Team physician will exam images but will be blinded from participant. Will only see participant number.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Jumping

Female jumping collegiate athletes

Group Type EXPERIMENTAL

POCUS

Intervention Type DIAGNOSTIC_TEST

Point of Care Ultrasound

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

POCUS

Point of Care Ultrasound

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-25 yr. old female student-athletes who participate in jump-centric activities
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Youngstown State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Morgan Bagley

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Morgan C Bagley, PhD

Role: PRINCIPAL_INVESTIGATOR

Faculty

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Youngstown State University

Youngstown, Ohio, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Morgan C Bagley, PhD

Role: CONTACT

330-941-3650

Matthew Campbell, PhD

Role: CONTACT

3309412576

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Morgan C Bagley, PhD

Role: primary

330-941-3650

Matthew Campbell, PhD

Role: backup

330-941-2576

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

YoungstownSU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.